A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 90 (3), 529-536
- https://doi.org/10.1016/s0090-8258(03)00332-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Multimodality therapy for patients with clinical Stage I and II malignant mixed M llerian tumors of the uterusCancer, 2001
- Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the GRUP ONCOLOGIC CATALÀ-OCCITÀInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteriCancer, 1998
- Uterine Carcinosarcomas: Incidence and Trends in Management and SurvivalGynecologic Oncology, 1997
- Radiotherapy in the Treatment of Uterine SarcomasGynecologic and Obstetric Investigation, 1996
- Treatment of uterine sarcomasCancer, 1990
- The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the UterusThe American Journal of Surgical Pathology, 1990
- Carcinosarcoma (Malignant Mixed Mesodermal Tumor) of the UterusInternational Journal of Gynecological Pathology, 1990
- Patterns of recurrence in malignant mixed müllerian tumor of the uterusCancer, 1986
- MIXED MESODERMAL SARCOMA OF THE UTERUSAmerican Journal of Roentgenology, 1973